123752_CHR_Chinwag_Jan_2020_Final

Corporate news

£3m for The Christie at Macclesfield

Fundraising for our new state of the art cancer centre in Macclesfield has now reached the £3mmark. The new centre will bring together essential cancer services into one purpose-built unit delivering local specialist access to radiotherapy, chemotherapy, holistic support and information services, outpatient care, palliative care, and a wider range of clinical trials. The Peel Group has agreed a £1m partnership with The Christie charity to help fund vital research into urological cancers. The pledge from the infrastructure, transport and real estate investment group will see two clinical researchers join The Christie’s uro-oncology department to oversee new studies in prostate, bladder and kidney cancer. The Peel Group will donate £200,000 a year for five years to fund the posts which it hopes will lead to advances in research that will have a positive impact on the future treatment of patients. Deputy Chairman of the Peel Group, Neil Lees said: “As a major contributor to the regional economy we wanted to pledge our support

Bringing The Christie to Cheshire: an artist’s impression of the new centre

charity, Louise Stimson said: “This is a fantastic start. There will be hundreds of fundraising activities and events in 2020, so plenty of opportunities for staff to get involved.” Work on the two storey building is expected to begin in May 2020 with the aim of opening during autumn 2021.

Dr Andrew Sykes, the lead consultant for the project said: “I can’t say a big enough thank you to everyone. The new centre will provide world class cancer care closer to home for 1,500 existing patients.” The Christie charity is aiming to raise £23m towards the £26.5m project. Head of fundraising at The Christie

The Peel Group announces £1 million research partnership

to an initiative which would have a positive impact on many people’s lives. We are delighted and excited to support this important research into urological cancers and we hope the legacy of this research benefits patients for many years to come.” The Christie’s uro-oncology department is at the forefront of cancer diagnosis and treatment in the UK and is a global leader in research. Professor Noel Clarke, consultant urological surgeon, said: “We are very grateful to The Peel Group for this investment and we are delighted to be able to invest in two new research posts which we hope will have a significant impact on our research into urological cancers.

“In order to continue to be at the forefront of cancer research and treatment, The Christie must continue to develop its academic and training capabilities, with scientists working alongside clinical teams. This funding will help us immensely in reaching our goals.” Important research: Neil Lees, Deputy Chairman of the Peel Group , Professor Ananya Choudhury, Professor Noel Clarke and Kate Holland from The Peel Group

11